Thermo Fisher Scientific Pre-Tax Income 2010-2024 | TMO

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Thermo Fisher Scientific annual pre-tax income for 2023 was $6.298B, a 19.62% decline from 2022.
Thermo Fisher Scientific annual pre-tax income for 2022 was $7.835B, a 11.38% decline from 2021.
Thermo Fisher Scientific annual pre-tax income for 2021 was $8.841B, a 22.28% increase from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Thermo Fisher Scientific annual pre-tax income for 2023 was $6.298B, a 19.62% decline from 2022.
Thermo Fisher Scientific annual pre-tax income for 2022 was $7.835B, a 11.38% decline from 2021.
Thermo Fisher Scientific annual pre-tax income for 2021 was $8.841B, a 22.28% increase from 2020.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$186.7B
Alcon (ALC)	$45.7B
IQVIA Holdings (IQV)	$39.5B
Edwards Lifesciences (EW)	$38.8B
IDEXX Laboratories (IDXX)	$35.5B
DexCom (DXCM)	$26.9B
Waters (WAT)	$22.9B
SONOVA HOLDING (SONVY)	$22B
STERIS (STE)	$21.3B
Hologic (HOLX)	$18.4B
Fresenius Medical Care AG KGaA (FMS)	$12.5B
Sysmex ADR (SSMXY)	$12.4B
Globus Medical (GMED)	$11.1B
Teleflex (TFX)	$9.2B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.6B
Glaukos (GKOS)	$7.7B
PROCEPT BioRobotics (PRCT)	$5B
Integer Holdings (ITGR)	$4.5B
Inari Medical (NARI)	$3B
TransMedics (TMDX)	$2.9B
Veracyte (VCYT)	$2.9B
LivaNova (LIVN)	$2.8B
Nihon Kohden (NHNKY)	$2.5B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.2B
Integra LifeSciences Holdings (IART)	$2B
RxSight (RXST)	$1.9B
Alphatec Holdings (ATEC)	$1.3B
Artivion (AORT)	$1.2B